Inhaler Comparison Tool
Your Situation
Select your key needs to find the best match:
Your Goals
Choose what matters most:
Recommended Inhaler
Select your situation and goals, then click "Find Best Match" to see the best inhaler for your needs.
Detailed Comparison
Attribute | Budez CR | Fluticasone | Beclomethasone | Montelukast |
---|---|---|---|---|
Drug Class | Inhaled Corticosteroid (Medium) | Inhaled Corticosteroid (High) | Inhaled Corticosteroid (Low-Moderate) | Leukotriene Receptor Antagonist |
Delivery Device | Dry Powder Inhaler | MDI or DPI | Dry Powder Inhaler | Oral Tablet |
Dosage Frequency | Twice Daily | Twice Daily | Once or Twice Daily | Once Daily |
Onset of Effect | Hours; Full in 2-3 Days | Hours; Full in 2-3 Days | Hours; Full in 2-3 Days | 24-48 Hours |
Size | Small Handheld | Medium | Small | N/A |
Estimated Annual Cost | $250-$350 | $300-$450 | $200-$320 | $120-$180 |
Trying to decide if Budez CR is right for you or if another inhaler might work better? You’re not alone. Millions of people with asthma or COPD face the same question every time they pick up a prescription. This guide breaks down the science, the experience, and the hard numbers so you can compare Budez CR with the most common alternatives side‑by‑side.
Quick Take
- Budez CR delivers budesonide, a medium‑potency inhaled corticosteroid (ICS), via a dry‑powder inhaler.
- Key alternatives include fluticasone propionate (e.g., Flovent), beclomethasone dipropionate (e.g., Qvar), and the leukotriene antagonist montelukast (Singulair).
- All options control inflammation, but delivery device, dosing frequency, and side‑effect profile differ.
- Cost and insurance coverage often tip the balance more than clinical efficacy.
- Choosing the right inhaler means matching the drug’s pharmacology to your lifestyle and symptom pattern.
What Is Budez CR?
Budez CR is a dry‑powder inhaler that contains budesonide, a synthetic glucocorticoid that reduces airway inflammation in asthma and COPD. The device uses breath‑actuated technology, so you only need to inhale sharply to release the medication.
Budesonide’s potency sits between low‑dose fluticasone and higher‑dose mometasone, making it a versatile choice for patients who need moderate control without a high steroid load.
How Does Budesonide Work?
When you inhale budesonide, it binds to glucocorticoid receptors in the airway epithelium, suppressing cytokine production and stabilizing mast cells. This reduces swelling, mucus, and hyper‑responsiveness. The effect begins within hours and peaks after a few days of regular use.
Because the drug is delivered directly to the lungs, systemic exposure is low-typically less than 1% of an oral dose-so side effects like adrenal suppression are rare when used as prescribed.
Major Alternatives at a Glance
Below are the most frequently prescribed inhaled corticosteroids or related agents that patients compare against Budez CR.
Fluticasone Propionate (e.g., Flovent)
Fluticasone propionate is a high‑potency inhaled corticosteroid delivered via metered‑dose inhaler (MDI) or dry‑powder inhaler (DPI). It offers strong anti‑inflammatory action with a twice‑daily dosing schedule.
Beclomethasone Dipropionate (e.g., Qvar)
Beclomethasone dipropionate is a low‑to‑moderate potency ICS that comes in a breath‑actuated DPI. Its particle size is optimized for deep lung delivery, allowing once‑daily use for many patients.
Montelukast (Singulair)
Montelukast is a leukotriene‑receptor antagonist taken orally once a day. It doesn’t replace an inhaled steroid but can be a useful add‑on, especially for exercise‑induced asthma.
Salbutamol (Albuterol)
Salbutamol is a short‑acting beta₂‑agonist (SABA) used as a rescue inhaler. It provides rapid bronchodilation but has no anti‑inflammatory effect.
Salmeterol (Long‑Acting Beta‑Agonist)
Salmeterol is a long‑acting beta₂‑agonist (LABA) that works for up to 12hours. It must be paired with an inhaled steroid like budesonide to be safe for asthma.

Side‑By‑Side Comparison Table
Attribute | Budez CR (Budesonide) | Fluticasone Propionate | Beclomethasone Dipropionate | Montelukast |
---|---|---|---|---|
Drug class | Inhaled corticosteroid (medium potency) | Inhaled corticosteroid (high potency) | Inhaled corticosteroid (low‑to‑moderate potency) | Leukotriene‑receptor antagonist |
Delivery device | Dry‑powder inhaler (breath‑actuated) | MDI or DPI | Dry‑powder inhaler (breath‑actuated) | Oral tablet |
Typical dose frequency | Twice daily (200‑400µg) | Twice daily (100‑250µg) | Once or twice daily (50‑200µg) | Once daily (10mg) |
Onset of anti‑inflammatory effect | Hours; full effect 2‑3days | Hours; full effect 2‑3days | Hours; full effect 2‑3days | 24‑48hours |
Typical inhaler size | Small handheld (approx. 130g) | Medium (≈150g for DPI) | Small (≈120g) | N/A (tablet) |
Annual out‑of‑pocket cost (US, average) | $250‑$350 | $300‑$450 | $200‑$320 | $120‑$180 |
FDA approval year (for asthma) | 1998 | 1993 | 1995 | 1998 |
How to Pick the Right Option for You
Here’s a quick decision framework. Ask yourself these three questions, then map your answers to the table above.
- Do you need a rescue medication or a controller? If you’re looking for daily inflammation control, stick with an inhaled steroid. For occasional flare‑ups, a SABA like salbutamol is essential.
- How comfortable are you with inhaler technique? Breath‑actuated DPIs (Budez CR, Beclomethasone) require a strong, fast inhalation. If that’s hard for you, an MDI with a spacer (fluticasone) might be easier.
- What does your insurance cover? Intuitively, cheaper options (beclomethasone, montelukast) often have better formulary placement. Check your pharmacy benefits before finalizing.
When the answers line up with a particular column, that drug‑device combo is a strong candidate. For example, if you struggle with coordination but need a potent steroid, fluticasone MDI with a spacer could beat Budez CR’s DPI for you.
Potential Side Effects to Watch
All inhaled corticosteroids share a core safety profile: local throat irritation, hoarseness, and a small risk of oral thrush. Systemic effects such as bone density loss or adrenal suppression are rare at recommended doses but become more likely with high‑dose or improper use.
- Budez CR: Slightly lower risk of oral candidiasis due to the dry‑powder formulation, but patients still need to rinse after use.
- Fluticasone: Higher potency can increase systemic exposure if over‑used; watch for bruising or mood changes.
- Beclomethasone: Often well tolerated; rare reports of dysphonia.
- Montelukast: Not an inhaled steroid, but can cause neuropsychiatric events (dream changes, mood swings) in a minority.
Practical Tips for Getting the Most Out of Your Inhaler
- Always exhale fully before loading the Budez CR inhaler.
- Seal your lips tightly around the mouthpiece and inhale sharply for 3‑4 seconds.
- Hold your breath for about 10 seconds after inhalation to allow particle deposition.
- Rinse your mouth with water (no swallowing) after each dose to prevent thrush.
- Set a daily alarm or use a medication app to keep dosing consistent.
Frequently Asked Questions
Is Budez CR suitable for children?
Yes. The dry‑powder inhaler is approved for patients six years and older, and the dose can be adjusted to as low as 100µg twice daily for pediatric asthma control. Always follow the pediatric dosing chart provided by your clinician.
Can I switch from fluticasone to Budez CR without a doctor’s visit?
A physician should supervise any switch between inhaled steroids. Although both drugs control inflammation, their potency and delivery devices differ, so a dose‑adjustment plan is essential to maintain control.
What if I forget a dose of Budez CR?
Take the missed dose as soon as you remember, unless it’s almost time for the next scheduled dose. In that case, skip the missed one and continue with your regular schedule-don’t double‑dose.
Is a spacer needed with Budez CR?
No. Budez CR’s breath‑actuated DPI releases the medication only when you inhale forcefully, so a spacer offers no benefit. If you have difficulty generating a strong inhalation, consider a different device.
How does cost compare across these options?
Based on average US retail prices in 2025, Budez CR ranges from $250‑$350 per year, fluticasone $300‑$450, beclomethasone $200‑$320, and montelukast $120‑$180. Insurance formularies can dramatically shift these numbers, so a quick check with your pharmacy benefits manager is wise.